Maxim Group resumed coverage on electroCore with a new price target
$ECOR
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Health Care
Maxim Group resumed coverage of electroCore with a rating of Buy and set a new price target of $3.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 1/19/2022 | $3.00 → $2.75 | Buy | HC Wainwright & Co. |
| 7/27/2021 | $3.00 | Buy | Ladenburg Thalmann |